This is a routine, de minimis insider sale by a director. No trading action warranted. Monitor for any larger insider sales or cluster filings that could signal a change in sentiment.
Price Chart
Executive Summary
Director Kimberly Manhard filed a Form 144 notice to sell 500 shares of Inhibrx Biosciences common stock, with an approximate market value of $55,130. The shares were acquired via open-market purchase in August 2024 and are held in a revocable trust. The proposed sale is very small relative to the director's total holdings and the company's $1.6B market cap, making it a routine portfolio adjustment with no material signal.
Key Facts
- Director Kimberly Manhard filed Form 144 to sell 500 shares of INBX common stock.
- Estimated value of the proposed sale is approximately $55,130.
- Shares were acquired via open-market purchase on 08/28/2024.
- Shares are held in the Kimberly Joan Manhard Revocable Trust.
- The sale represents a tiny fraction of the director's total holdings and the company's $1.6B market cap.
Financial Impact
Proposed sale of 500 shares valued at approximately $55,130 — negligible relative to $1.6B market cap.
Risk Factors
- Insider selling could accelerate if additional Form 144 filings appear at higher volume.
- No other material risks from this isolated filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-006953 |
| Document: 0001959173-26-006953.txt | 0001959173-26-006953 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | Insider Buy | $90.50 | awaiting T+60 | — | $95.66 (+5.70%) |
Sep 28, 2026 28d ago | Insider Cluster | $104.83 | awaiting T+60 | — | $95.66 (−8.75%) |
Sep 17, 2026 5w ago | Insider Cluster | $109.35 | awaiting T+60 | — | $95.66 (−12.52%) |
Sep 15, 2026 5w ago | Insider Cluster | $101.77 | awaiting T+60 | — | $95.66 (−6.00%) |
Sep 15, 2026 6w ago | 144 | $101.77 | awaiting T+60 | — | $95.66 (−6.00%) |
Sep 14, 2026 6w ago | 144 | $105.61 | awaiting T+60 | — | $95.66 (−9.42%) |
Sep 11, 2026 6w ago | 144 | $109.27 | awaiting T+60 | — | $95.66 (−12.46%) |
Sep 10, 2026 6w ago | Insider Cluster | $109.27 | awaiting T+60 | — | $95.66 (−12.46%) |
Sep 8, 2026 7w ago | Insider Cluster | $112.86 | awaiting T+60 | — | $95.66 (−15.24%) |
Sep 8, 2026 7w ago | Insider Buy | $112.86 | awaiting T+60 | — | $95.66 (−15.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers